Clinical Trial Update: Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a multi-targeted cardiac risk intervention in type 2 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Providence VA Medical Center | Conditions: Diabetes, Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2014-04-11